Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved.
The post GLP-1s Come With High Price Tags and Major Side Effects. Could Microdosing Be the Answer? appeared first on MedCity News.
